Announced Mon, 13 Jul · 18:50 IST
RTA certifies dematerialisation compliance for Q1 FY27
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.5%1-day move
₹71.89
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-2.5-1.3-2.5-5.1-0.4-1.2————
Up moveDown movePending
AI summary
Concord Drugs submitted a certificate from its Registrar and Share Transfer Agent, Aarthi Consultants Pvt Ltd, under SEBI Regulation 74(5) for the quarter ended 30 June 2026. The RTA confirms it mutilated and cancelled physical share certificates received from depository participants and updated the depository as the registered owner within 15 days. This is a routine quarterly compliance filing and not a material corporate action.
Likely market impact
No impact on shareholders or stock. Routine regulatory compliance with no business or price implications.